{"date":"2025-06-11","count":53,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6949-2025-06-11-1912-1rnaody","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"19:12:58","subject":"董事會決議參與認購台灣細胞製造股份有限公司現金增資案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-06-11 19:12，「董事會決議參與認購台灣細胞製造股份有限公司現金增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-06-11-1908-lbsdng","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"19:08:56","subject":"公告法人董事指派代表人出席114/06/11董事會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-06-11 19:08，「公告法人董事指派代表人出席114/06/11董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-06-11-1907-9rsrv0","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"19:07:33","subject":"本公司114年股東常會通過解除董事競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-06-11 19:07，「本公司114年股東常會通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-06-11-1906-1863nbk","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"19:06:31","subject":"公告本公司民國114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-06-11 19:06，「公告本公司民國114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-06-11-1839-19tn1ty","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"18:39:58","subject":"公告本公司現金增資發行新股認股基準日及發行相關事宜","clause":"第9款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-06-11 18:39，「公告本公司現金增資發行新股認股基準日及發行相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2025-06-11-1836-1cvik2w","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"18:36:26","subject":"公告本公司審計委員委員任期屆滿改選","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2025-06-11 18:36，「公告本公司審計委員委員任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2025-06-11-1836-1ifbulk","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"18:36:10","subject":"公告本公司董事會推選副董事長","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2025-06-11 18:36，「公告本公司董事會推選副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2025-06-11-1835-s0kpz3","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"18:35:51","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2025-06-11 18:35，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2025-06-11-1835-10udtbs","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"18:35:27","subject":"公告本公司114年股東常會決議許可新任董事及其代表人從事競業行為","clause":"第22款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2025-06-11 18:35，「公告本公司114年股東常會決議許可新任董事及其代表人從事競業行為」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2025-06-11-1835-19lgm63","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"18:35:09","subject":"公告本公司114年股東常會改選董事九名(含獨立董事三名)董事當選名單","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2025-06-11 18:35，「公告本公司114年股東常會改選董事九名(含獨立董事三名)董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2025-06-11-1834-ds864w","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"18:34:41","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2025-06-11 18:34，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-06-11-1815-1bcv4sg","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"18:15:21","subject":"公告本公司取得會計師內部控制制度專案審查確信報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-06-11 18:15，「公告本公司取得會計師內部控制制度專案審查確信報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-06-11-1737-qflmkr","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"17:37:58","subject":"公告本公司董事會通過委任風險管理委員會委員","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-06-11 17:37，「公告本公司董事會通過委任風險管理委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2025-06-11-1736-1ljbpe0","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"17:36:58","subject":"公告本公司審計委員會第三屆委員","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2025-06-11 17:36，「公告本公司審計委員會第三屆委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-06-11-1735-1skn09x","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"17:35:59","subject":"公告本公司董事會通過委任提名委員會委員","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-06-11 17:35，「公告本公司董事會通過委任提名委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2025-06-11-1733-hjxke8","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"17:33:11","subject":"公告本公司選任第十一屆董事長","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2025-06-11 17:33，「公告本公司選任第十一屆董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-06-11-1731-1mve6xu","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"17:31:57","subject":"公告本公司董事會通過委任薪資報酬委員會委員","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-06-11 17:31，「公告本公司董事會通過委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-06-11-1730-13sk2v0","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"17:30:14","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-06-11 17:30，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2025-06-11-1728-isqttc","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"17:28:54","subject":"公告本公司董事會重要決議事項","clause":"第44款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2025-06-11 17:28，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-06-11-1728-17ub2xu","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"17:28:15","subject":"公告本公司2025年股東常會通過解除新任董事競業禁止之限制案","clause":"第21款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-06-11 17:28，「公告本公司2025年股東常會通過解除新任董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-06-11-1726-q7smso","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"17:26:14","subject":"公告本公司2025年股東常會補選一席獨立董事當選名單","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-06-11 17:26，「公告本公司2025年股東常會補選一席獨立董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-06-11-1723-cc5145","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"17:23:47","subject":"公告本公司2025年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-06-11 17:23，「公告本公司2025年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2025-06-11-1717-14qnhj6","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"17:17:44","subject":"公告本公司股東常會決議通過解除新任董事競業禁止案","clause":"第22款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2025-06-11 17:17，「公告本公司股東常會決議通過解除新任董事競業禁止案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2025-06-11-1715-yduozm","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"17:15:15","subject":"公告本公司114年股東常會全面改選董事7席(含獨立董事3席)","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2025-06-11 17:15，「公告本公司114年股東常會全面改選董事7席(含獨立董事3席)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2025-06-11-1713-m94erf","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"17:13:17","subject":"公告本公司庫藏股註銷減資變更登記完成","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2025-06-11 17:13，「公告本公司庫藏股註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2025-06-11-1700-ds864w","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"17:00:55","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2025-06-11 17:00，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-06-11-1656-10m1k6c","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"16:56:25","subject":"公告本公司114年股東常會通過解除董事及其代表人競業禁止限制案","clause":"第22款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-06-11 16:56，「公告本公司114年股東常會通過解除董事及其代表人競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-06-11-1648-d9bwy4","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"16:48:34","subject":"公告本公司114年度股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-06-11 16:48，「公告本公司114年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-06-11-1620-whk7yl","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"16:20:35","subject":"公告本公司TAH3311取得南非「ApixabanFilm Product and Uses Thereof」發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-06-11 16:20，「公告本公司TAH3311取得南非「ApixabanFilm Product and Uses Thereof」發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-06-11-1617-54swv6","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"16:17:41","subject":"公告本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-06-11 16:17，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-06-11-1605-13yvzxa","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"16:05:49","subject":"公告本公司第二屆薪酬委員會委員","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-06-11 16:05，「公告本公司第二屆薪酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-06-11-1605-404p2v","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"16:05:20","subject":"公告本公司第二屆審計委員會委員","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-06-11 16:05，「公告本公司第二屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-06-11-1604-9769qc","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"16:04:52","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-06-11 16:04，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-06-11-1604-1udd9xf","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"16:04:15","subject":"公告本公司新任法人董事指派代表人","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-06-11 16:04，「公告本公司新任法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-06-11-1603-1ssbmvi","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-06-11","time":"16:03:17","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-06-11 16:03，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-06-11-1558-ds864w","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-11","time":"15:58:36","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-06-11 15:58，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-06-11-1551-f8ozg1","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"15:51:30","subject":"公告本公司114年股東會決議解除新任董事及其代表人競業禁止限制案","clause":"第21款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-06-11 15:51，「公告本公司114年股東會決議解除新任董事及其代表人競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-06-11-1549-nlvxew","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"15:49:13","subject":"公告本公司114年股東常會改選董事(含獨立董事)","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-06-11 15:49，「公告本公司114年股東常會改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-06-11-1545-ds864w","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"15:45:07","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-06-11 15:45，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-06-11-1518-1d8kaer","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"15:18:58","subject":"公告本公司國內第三次無擔保轉換公司債代收價款專戶及存儲專戶行庫","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-06-11 15:18，「公告本公司國內第三次無擔保轉換公司債代收價款專戶及存儲專戶行庫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-06-11-1416-1c6zp0i","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"14:16:30","subject":"公告本公司第三屆薪資報酬委員會委員名單","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-06-11 14:16，「公告本公司第三屆薪資報酬委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-06-11-1415-8ysypv","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"14:15:55","subject":"公告本公司第三屆審計委員會委員名單","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-06-11 14:15，「公告本公司第三屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-06-11-1415-1gm77fo","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"14:15:21","subject":"公告本公司董事會選任董事長案","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-06-11 14:15，「公告本公司董事會選任董事長案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-06-11-1414-1dgidhm","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"14:14:16","subject":"公告本公司股東會決議解除新任董事及其代表人之競業禁止限制","clause":"第21款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-06-11 14:14，「公告本公司股東會決議解除新任董事及其代表人之競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-06-11-1413-19o1zaj","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"14:13:52","subject":"公告本公司114年股東常會全面改選董事之當選名單","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-06-11 14:13，「公告本公司114年股東常會全面改選董事之當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2025-06-11-1413-4rizfg","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"14:13:24","subject":"本公司114年股東會重要決議事項","clause":"第18款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2025-06-11 14:13，「本公司114年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2025-06-11-1335-ds864w","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"13:35:04","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2025-06-11 13:35，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2025-06-11-1303-1eg7zug","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"13:03:37","subject":"本公司股東常會決議通過解除董事競業禁止之限制","clause":"第21款","fact_date":"2025-06-10","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2025-06-11 13:03，「本公司股東常會決議通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2025-06-11-1114-18frmf7","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"11:14:22","subject":"公告本公司第十四屆董事長及副董事長選任案","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2025-06-11 11:14，「公告本公司第十四屆董事長及副董事長選任案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2025-06-11-1113-2bv7oi","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"11:13:31","subject":"公告本公司委任第二屆審計委員會委員","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2025-06-11 11:13，「公告本公司委任第二屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2025-06-11-1106-qnyowe","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"11:06:53","subject":"公告本公司股東常會改選董事相關事宜","clause":"第6款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2025-06-11 11:06，「公告本公司股東常會改選董事相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2025-06-11-1058-rsxpvq","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"10:58:48","subject":"公告本公司股東會通過解除法人董事代表人競業禁止之限制案","clause":"第21款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2025-06-11 10:58，「公告本公司股東會通過解除法人董事代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2025-06-11-1054-ds864w","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2025-06-11","time":"10:54:20","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2025-06-11 10:54，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}